| RS1057517634 |
POLE
|
Health Risk |
Likely pathogenic |
Colorectal cancer, susceptibility to |
| RS1057517636 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1057517637 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1057517641 |
RAD51C
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS1057517643 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1057517647 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1057517648 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group J, Hereditary cancer-predisposing syndrome |
| RS1057517661 |
GAL
|
Health Risk |
Pathogenic |
Familial temporal lobe epilepsy 8, Familial temporal lobe epilepsy 8 |
| RS1057517662 |
SPARC
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 17, Osteogenesis imperfecta type 17 |
| RS1057517663 |
SPARC
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 17, Osteogenesis imperfecta type 17 |
| RS1057517664 |
SLC1A4
|
Health Risk |
Pathogenic |
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome, Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome |
| RS1057517666 |
SLC18A3
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 21, Congenital myasthenic syndrome 21 |
| RS1057517667 |
ZIC1
|
Health Risk |
Pathogenic |
Structural brain anomalies with impaired intellectual development and craniosynostosis, Structural brain anomalies with impaired intellectual development and craniosynostosis |
| RS1057517668 |
ZIC1
|
Health Risk |
Pathogenic |
Structural brain anomalies with impaired intellectual development and craniosynostosis, Structural brain anomalies with impaired intellectual development and craniosynostosis |
| RS1057517669 |
ZIC1
|
Health Risk |
Pathogenic |
Structural brain anomalies with impaired intellectual development and craniosynostosis, Structural brain anomalies with impaired intellectual development and craniosynostosis |
| RS1057517670 |
ZIC1
|
Health Risk |
Pathogenic |
Craniosynostosis 6, Craniosynostosis 6 |
| RS1057517671 |
GPR68
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, hypomaturation type |
| RS1057517672 |
GPR68
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, hypomaturation type |
| RS1057517673 |
KIF5A
|
Health Risk |
Pathogenic |
Myoclonus, intractable |
| RS1057517674 |
MAD2L2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group V, Fanconi anemia complementation group V |
| RS1057517675 |
RNASEH1
|
Health Risk |
Pathogenic |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 |
| RS1057517676 |
EDC3
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 50 |
| RS1057517677 |
UNC13A
|
Health Risk |
Conflicting classifications of pathogenicity |
UNC13A-related disorder, UNC13A-related disorder |
| RS1057517678 |
PPA2
|
Health Risk |
Pathogenic |
Sudden cardiac failure, infantile |
| RS1057517679 |
PPA2
|
Health Risk |
Pathogenic |
Sudden cardiac failure, infantile |
| RS1057517680 |
PPA2
|
Health Risk |
Pathogenic |
Sudden cardiac failure, infantile |
| RS1057517681 |
PADI6
|
Health Risk |
Pathogenic |
Preimplantation embryonic lethality 2, Preimplantation embryonic lethality 2 |
| RS1057517682 |
PADI6
|
Health Risk |
Pathogenic |
Preimplantation embryonic lethality 2, Preimplantation embryonic lethality 2 |
| RS1057517683 |
PADI6
|
Health Risk |
Pathogenic |
Preimplantation embryonic lethality 2, Preimplantation embryonic lethality 2 |
| RS1057517684 |
PADI6
|
Health Risk |
Likely pathogenic |
Preimplantation embryonic lethality 2, Preimplantation embryonic lethality 2 |
| RS1057517685 |
TRMT5
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 26, Combined oxidative phosphorylation defect type 26 |
| RS1057517686 |
ATAD3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Harel-Yoon syndrome, Harel-Yoon syndrome |
| RS1057517687 |
ATAD3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Harel-Yoon syndrome, Pontocerebellar hypoplasia |
| RS1057517688 |
MFSD2A
|
Health Risk |
Pathogenic |
Microcephaly 15, primary |
| RS1057517689 |
MFSD2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 15, primary |
| RS1057517691 |
CEP78
|
Health Risk |
Pathogenic |
Cone-rod dystrophy and hearing loss 1, Cone-rod dystrophy and hearing loss 1 |
| RS1057517692 |
CEP78
|
Health Risk |
Pathogenic |
Cone-rod dystrophy and hearing loss 1, Retinal dystrophy |
| RS1057517693 |
CEP78
|
Health Risk |
Pathogenic |
Cone-rod dystrophy and hearing loss 1, Cone-rod dystrophy and hearing loss 1 |
| RS1057517694 |
CEP78
|
Health Risk |
Pathogenic |
Cone-rod dystrophy and hearing loss 1, Cone-rod dystrophy |
| RS1057517695 |
CEP78
|
Health Risk |
Pathogenic |
Cone-rod dystrophy and hearing loss 1, Sensorineural hearing loss disorder |
| RS1057517696 |
TMTC3
|
Health Risk |
Pathogenic |
Lissencephaly 8, Lissencephaly 8 |
| RS1057517697 |
TMTC3
|
Health Risk |
Pathogenic |
Lissencephaly 8, Lissencephaly 8 |
| RS1057517698 |
TMTC3
|
Health Risk |
Pathogenic |
Lissencephaly 8, Lissencephaly 8 |
| RS1057517699 |
TECRL
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 3, Catecholaminergic polymorphic ventricular tachycardia 3 |
| RS1057517700 |
ABCA4
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 19, Retinal dystrophy |
| RS1057517701 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1057517704 |
ARID1B
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS1057517705 |
ARX
|
Health Risk |
Pathogenic |
— |
| RS1057517706 |
ATP2C1
|
Health Risk |
Pathogenic |
Familial benign pemphigus, Familial benign pemphigus |
| RS1057517707 |
ATRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-hypotonic facies syndrome, X-linked |
| RS1057517708 |
AUTS2
|
Health Risk |
Pathogenic |
Intellectual disability, Autism spectrum disorder due to AUTS2 deficiency |
| RS1057517709 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS1057517710 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS1057517711 |
CACNA1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 1, Long QT syndrome |
| RS1057517712 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1057517713 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1057517714 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS1057517715 |
CHM
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1057517716 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1057517717 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1057517718 |
CLCN7
|
Health Risk |
Pathogenic |
Hypopigmentation, organomegaly |
| RS1057517719 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057517720 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1057517721 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa, Epidermolysis bullosa |
| RS1057517722 |
COL7A1
|
Health Risk |
Pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS1057517723 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica inversa |
| RS1057517724 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Recessive dystrophic epidermolysis bullosa, COL7A1-related disorder |
| RS1057517725 |
COL7A1
|
Health Risk |
Pathogenic |
7 conditions, 7 conditions |
| RS1057517726 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1057517729 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1057517730 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1057517731 |
EDA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1057517732 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Multiple congenital anomalies |
| RS1057517733 |
FBP1
|
Health Risk |
Pathogenic |
Fructose-biphosphatase deficiency, FBP1-related disorder |
| RS1057517734 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, FH-related disorder |
| RS1057517735 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1057517736 |
FOXP3
|
Health Risk |
Pathogenic |
— |
| RS1057517738 |
GLB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-B |
| RS1057517739 |
GPC3
|
Health Risk |
Pathogenic |
— |
| RS1057517741 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1057517742 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS1057517743 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome 2 |
| RS1057517744 |
HNF1B
|
Health Risk |
Pathogenic |
Renal cysts and diabetes syndrome, Maturity-onset diabetes of the young |
| RS1057517745 |
HNF4A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1057517746 |
IKBKG
|
Health Risk |
Pathogenic |
— |
| RS1057517747 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS1057517749 |
INPP5E
|
Health Risk |
Likely pathogenic |
— |
| RS1057517752 |
KRIT1
|
Health Risk |
Pathogenic |
— |
| RS1057517753 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Hereditary cavernous hemangioma of brain |
| RS1057517754 |
KRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1057517756 |
LAMA1
|
Health Risk |
Likely pathogenic |
— |
| RS1057517758 |
MAP3K7
|
Health Risk |
Likely pathogenic |
— |
| RS1057517759 |
MAT1A
|
Health Risk |
Pathogenic |
Hepatic methionine adenosyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency |
| RS1057517760 |
MEN1
|
Health Risk |
Likely pathogenic |
— |
| RS1057517761 |
MPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS1057517762 |
MSH2
|
Health Risk |
Pathogenic |
— |
| RS1057517763 |
MSH6
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1057517764 |
MSH6
|
Health Risk |
Pathogenic |
Carcinoma of colon, Hereditary cancer-predisposing syndrome |
| RS1057517765 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1057517766 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |